Purchase Order 75N95021P00209

<p>This is a $4,995,600.00 purchase order contract awarded by the National Institute of Neurological Disorders and Stroke, a civilian agency, to Biologics Consulting Group, Inc. for biologics subject matter expert consulting services. The contract is not set aside and has a period of performance ending on September 25, 2027. Biologics Consulting Group, Inc. is a for-profit Subchapter S corporation located in Alexandria, Virginia.</p>

This is a $6,000 firm-fixed-price purchase order awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health (NIH), to Hongjun Wang, a self-certified small disadvantaged business, for biological therapeutics product development subject matter expert consulting services to support the development of cell and gene therapy products. The contract is a total small business set-aside under NAICS code 541690 (All Scientific and...

This federal contract award, valued at $1,884,275.00, was issued by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency, to Pharmalex US Corporation for Biologics Subject Matter Expert (SME) Consulting Services. The contract is a total small business set-aside, with a period of performance through April 14, 2025. The award is in support of NINDS programs such as the Blueprint Neurotherapeutics Network Biologics (BPN-Biologics), the Ultra-Rare Gene Therapy...

This purchase order contract valued at $568,500 was awarded by the National Institutes of Health's National Institute of Neurological Disorders and Stroke to Dr. Gian Luca Araldi as the prime contractor. The contract is for process chemistry consulting services to support the NIH Blueprint Neurotherapeutics Network and NIH Helping to End Addiction Long-term Initiative programs. Dr. Araldi will provide technical guidance and support as the key personnel consultant over a three-year period...

Organix Chemistry Solutions LLC was awarded a $3.677 million delivery order against the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences' CRO Support for NCATS Medicinal Chemistry for Lead Optimization master IDIQ contract. The delivery order, issued for the period of September 28, 2020 through September 27, 2022, provides synthetic chemistry support services to the TDB Medicinal Chemistry Team. Key services will involve...

The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences (NCATS) awarded a firm fixed price purchase order to Integrated DNA Technologies, Inc. (IDT) for the custom synthesis of 1,536 antisense oligonucleotides targeting the CHCHD10 gene. The $102,915.50 contract has an August 29, 2022 completion date and does not have a set-aside designation. IDT is a manufacturer of nucleic acid products that has previously supported...

This non-competitive contract award from the National Institutes of Health's National Center for Advancing Translational Sciences to Integrated DNA Technologies, Inc. is for $20,026.50 to provide custom synthesis of nine antisense oligonucleotides for a neurotoxicology study. Per the solicitation, IDT will synthesize the oligos using proprietary machines and deliver the highest accuracy in sequence. They will also offer design support and expertise. The period of performance is August 7-21,...

This federal contract award is for &quot;CHEMISTRY, MANUFACTURING, AND CONTROLS (CMC) DEVELOPMENT OF NCGC00413972 FOR PRECLINICAL SAFETY EVALUATION AND CLINICAL TRIAL&quot; and was issued to Curia Global Inc., doing business as Amri. The contract, valued at $907,791.77, is a delivery order under the &quot;CRO Support for NCATS Drug Substance Development and Manufacture&quot; indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. The National Center for Advancing Translational...

This purchase order contract was awarded by the National Institutes of Health's National Center for Advancing Translational Sciences to Integrated DNA Technologies, Inc. for $28,510.03. Under the terms of the contract, IDT will provide custom synthesis, purification, normalization, and delivery of nine antisense oligonucleotides to the National Institute on Drug Abuse by August 15, 2023. The ASOs will support neurotoxicity studies evaluating a potential platform for predicting adverse effects of...

This is a $245,400 firm-fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to RPK Associates, LLC, a small business, for biological therapeutics product development subject matter expert consulting services. The contract supports the development of therapeutic biotechnology products (biologics) and includes option periods through November 16, 2025. The contract was awarded...